Source:http://linkedlifedata.com/resource/pubmed/id/11518776
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2001-8-23
|
pubmed:abstractText |
In ischemia, nitric oxide (NO) production is increased, possibly to preserve flow. The role of NO was investigated in hypertensive patients with or without renal artery stenosis (RAS). Fifty-five hypertensive patients scheduled to undergo diagnostic renal angiography underwent mean renal blood flow (MRBF) measurements before and after an intrarenal injection of the NO synthase blocker N(g)-monomethyl-L-arginine (L-NMMA) at 0.03 microg/kg, before angiography. A dose-response study indicated that this dose of L-NMMA significantly blocked NO synthesis. MRBF was measured at baseline and 1, 5, 10, and 20 min after L-NMMA treatment. On the basis of the angiographic results, patients were divided into three diagnostic categories, i.e., essential hypertension (n = 26), unilateral RAS (n = 16), or bilateral RAS (n = 8). In essential hypertension, MRBF was decreased by 18 +/- 4% at 20 min. In unilateral RAS, L-NMMA did not affect MRBF in the stenotic kidney but reduced MRBF in the nonstenotic kidney by 40 +/- 9% at 20 min. In bilateral RAS, L-NMMA reduced flow by 32 +/- 14% at 20 min. In the nonstenotic kidney in unilateral RAS, a positive correlation was observed between the effect of NO blockade on MRBF and arterial renin levels (P = 0.009). In the stenotic kidney, in contrast, this correlation was inverse (P = 0.007). In conclusion, MRBF depends on NO in hypertensive patients, except in the stenotic kidney in unilateral RAS. In the nonstenotic kidney in unilateral RAS, NO bioavailability is increased. It is suggested that a compensatory mechanism, regulated by NO and possibly angiotensin II, may preserve renal function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Renin,
http://linkedlifedata.com/resource/pubmed/chemical/omega-N-Methylarginine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1046-6673
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1836-43
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11518776-Angiography,
pubmed-meshheading:11518776-Angiotensin II,
pubmed-meshheading:11518776-Dose-Response Relationship, Drug,
pubmed-meshheading:11518776-Enzyme Inhibitors,
pubmed-meshheading:11518776-Female,
pubmed-meshheading:11518776-Humans,
pubmed-meshheading:11518776-Hypertension,
pubmed-meshheading:11518776-Male,
pubmed-meshheading:11518776-Middle Aged,
pubmed-meshheading:11518776-Nitric Oxide,
pubmed-meshheading:11518776-Reference Values,
pubmed-meshheading:11518776-Renal Artery Obstruction,
pubmed-meshheading:11518776-Renal Circulation,
pubmed-meshheading:11518776-Renin,
pubmed-meshheading:11518776-Severity of Illness Index,
pubmed-meshheading:11518776-omega-N-Methylarginine
|
pubmed:year |
2001
|
pubmed:articleTitle |
Nitric oxide dependence of renal blood flow in patients with renal artery stenosis.
|
pubmed:affiliation |
Department of Internal Medicine, University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
|
pubmed:publicationType |
Journal Article
|